Global Precision Medicine Market By Products & Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, NGS, Others), By Application (Oncology, Cardiology, Respiratory, Neurology, Immunology, Others), By End User (Pharmaceutical and Biotechnology Companies, Healthcare IT, Diagnostic Companies, Clinical Research Organization, Research Institutes), By Region, Competition Forecast & Opportunities, 2021-2031F

  • Industry : Healthcare
  • Pages : 216
  • Published Date : December, 2025

Customization Enquiry

Buy Now
The report will be delivered in PDF format but without printing rights. It is recommended for individual clients for their personal use only.
Single User Licence $4500
The report will be delivered in printable PDF format along with the report’s data excel sheet for internal analysis. It is strongly recommended for a corporate team or an organization where users would like to access the report from multiple locations.!
Multi-User Licence $5500
The report will be delivered in printable PDF format along with the report’s data excel sheet. This license offers free 80 Analyst hours where the client can use TechSci’s research team. It is strongly recommended for an organization which wants to execute short ‘bespoke’ research project related to the scope of the purchased report.!
Custom Research Licence $8000
Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 118.35 Billion

CAGR (2026-2031)

11.51%

Fastest Growing Segment

Bioinformatics

Largest Market

North America

Market Size (2031)

USD 227.54 Billion

Market Overview

The Global Precision Medicine Market will grow from USD 118.35 Billion in 2025 to USD 227.54 Billion by 2031 at a 11.51% CAGR. Precision medicine is an innovative approach to disease treatment and prevention that accounts for individual variability in genes, environment, and lifestyle for each person. The primary drivers propelling this market include the decreasing costs of genomic sequencing, the rising prevalence of complex chronic diseases such as cancer, and the growing demand for targeted therapies that minimize adverse drug reactions. According to the Personalized Medicine Coalition, in 2024, the U.S. Food and Drug Administration approved 18 new personalized medicines, representing approximately 38% of all newly approved therapeutic molecular entities. This statistic highlights the accelerating shift in pharmaceutical development toward targeted interventions that offer higher efficacy rates compared to traditional one-size-fits-all approaches.

However, the market encounters a significant challenge regarding reimbursement structures and the high cost of implementation. Insurers and healthcare payers frequently struggle to establish consistent coverage policies for these expensive therapies due to the complexity of interpreting genetic data and proving long-term cost-effectiveness. Consequently, the financial uncertainty surrounding reimbursement for both diagnostic tests and subsequent targeted treatments creates a barrier to access, potentially stalling the broader adoption of precision medicine solutions across global healthcare systems.

Key Market Drivers

Advancements in next-generation sequencing (NGS) and the concomitant decline in genomic profiling costs constitute the most foundational drivers of the precision medicine market. These technological breakthroughs have shifted genetic analysis from expensive research projects to routine clinical diagnostics, enabling the widespread identification of actionable mutations. According to 3billion.io, in 2024, the cost of sequencing a human genome plummeted to approximately $600, significantly lowering the barrier to entry for healthcare systems and patients alike. This affordability has directly fueled an explosion in data generation, creating a robust ecosystem for personalized care. Highlighting this scale of operation, according to Illumina, in June 2025, an average of 10 human genomes were sequenced every minute on their platforms throughout 2024, demonstrating the massive volume of genomic data now available to drive targeted treatment decisions.

Concurrently, the integration of artificial intelligence and big data analytics is critical for operationalizing this vast genetic information. As the volume of genomic and phenotypic data expands, AI-driven tools are becoming indispensable for interpreting complex datasets, identifying novel biomarkers, and predicting patient responses with high fidelity. This technological synergy is rapidly gaining regulatory validation, furthering its adoption in clinical settings. According to HealthExec, in July 2025, the U.S. Food and Drug Administration had cleared a total of 1,247 clinical artificial intelligence algorithms, signaling a decisive shift toward computational diagnostics. This growing regulatory acceptance allows market players to deploy sophisticated predictive models that enhance the efficacy of personalized therapies, thereby cementing AI as a central pillar of the global precision medicine infrastructure.

Download Free Sample Report

Key Market Challenges

The complex and inconsistent landscape of reimbursement, combined with high implementation costs, acts as a formidable barrier to the growth of the Global Precision Medicine Market. Healthcare providers and payers frequently disagree on the clinical utility and economic value of expensive genomic profiling and targeted therapies, leading to unpredictable coverage policies. This financial uncertainty discourages medical institutions from upgrading their diagnostic infrastructure and creates hesitation among pharmaceutical developers who face risks that their innovations will not be commercially viable. Consequently, patients often face prohibitive out-of-pocket costs, which significantly stifles the adoption rates of these advanced medical solutions.

This lack of uniform coverage is quantifiable and highlights the fragmentation within the market. According to the American Cancer Society Cancer Action Network, in 2024, only 16 U.S. states had successfully enacted legislation requiring comprehensive insurance coverage for biomarker testing, leaving the majority of the country with restrictive or undefined access protocols. This regulatory inconsistency forces companies to navigate a patchwork of payer policies, delaying market entry and limiting the potential revenue scale of precision medicine technologies globally.

Key Market Trends

The increasing adoption of liquid biopsy for non-invasive disease monitoring is shifting clinical practice toward frequent, blood-based molecular surveillance. This trend is particularly significant in oncology, where circulating tumor DNA analysis enables real-time tracking of minimal residual disease. The scalability of this approach is evident in the rapid volume growth reported by leading diagnostic providers. According to Natera, February 2025, in the 'Fourth Quarter and Full Year 2024 Financial Results', the company performed approximately 528,200 oncology tests in 2024, representing a 54.9% increase compared to the previous year. This utilization increase highlights the growing reliance on longitudinal monitoring to detect recurrence earlier than traditional imaging.

Simultaneously, precision medicine applications are expanding into Central Nervous System (CNS) diseases, moving beyond the market's concentration on oncology. This diversification is driven by the validation of blood-based biomarkers for neurodegenerative conditions, which offer scalable alternatives to expensive PET scans. These tools significantly enhance patient identification for targeted CNS therapies. According to Quest Diagnostics, April 2025, in the 'Quest Diagnostics Launches New AD-Detect Blood Test to Aid in Confirming Alzheimer's Disease' press release, research presented at the 2025 AAN Annual Meeting demonstrated that their new blood test achieved 91% sensitivity and specificity in detecting Alzheimer’s disease pathology. This diagnostic fidelity is pivotal for operationalizing precision care in neurology.

Segmental Insights

The Bioinformatics segment is currently registering the fastest growth within the Global Precision Medicine Market. This expansion is primarily driven by the significant increase in biological data generated from genomic sequencing projects. Pharmaceutical companies and research institutions require specialized computational tools to organize and interpret these vast datasets for drug discovery and personalized treatment development. Additionally, supportive initiatives by organizations such as the National Institutes of Health regarding data sharing and public genomic databases have accelerated the adoption of bioinformatics solutions, facilitating the efficient translation of biological data into clinical applications.

Regional Insights

North America commands the leading position in the global precision medicine market, driven by substantial investment in genomic research and a robust healthcare infrastructure. The region benefits significantly from government initiatives that prioritize personalized care models, particularly in the United States. Furthermore, the US Food and Drug Administration plays a critical role by establishing clear pathways for the approval of companion diagnostics and targeted therapies. The concentration of key pharmaceutical companies and research institutions in this geography further accelerates the development and commercialization of new medical solutions, ensuring sustained market dominance.

Recent Developments

  • In September 2024, Tempus AI expanded its existing collaboration with Takeda to further integrate data-driven approaches into oncology research and development. This enhanced partnership leverages Tempus's extensive multimodal real-world datasets and biological modeling capabilities to support Takeda's pipeline of cancer therapeutics, including antibody-drug conjugates. Under the agreement, Takeda gains access to an advanced analytics platform and a library of patient-derived tumor organoids to generate actionable insights and simulate therapeutic responses. The initiative aims to accelerate the discovery of novel targets and improve the design of clinical trials, thereby facilitating the delivery of more precise and effective treatments to cancer patients.
  • In August 2024, Illumina announced that the U.S. Food and Drug Administration approved its TruSight Oncology Comprehensive test along with two companion diagnostic indications. This in vitro diagnostic kit profiles over 500 genes to identify somatic variants in solid tumors, enabling comprehensive genomic profiling for cancer patients. The approval allows the test to serve as a companion diagnostic to identify patients who may benefit from targeted therapies developed by Bayer and Eli Lilly. By providing a distributed, clinically actionable solution, this launch expands access to precision oncology, allowing laboratories to match patients with personalized treatment options based on their specific tumor biomarkers.
  • In July 2024, Guardant Health received approval from the U.S. Food and Drug Administration for its Shield blood test, marking a significant milestone in non-invasive cancer screening. This approval established the product as the first blood-based primary screening option for colorectal cancer that meets the performance requirements for Medicare coverage. Designed for average-risk adults aged 45 and older, the diagnostic offers a convenient alternative to traditional methods like colonoscopy, potentially increasing screening adherence. The test utilizes a multimodal approach to detect colorectal cancer signals in the bloodstream, supporting early detection and the precision management of the disease.
  • In March 2024, Bayer entered into a strategic collaboration with Aignostics to advance precision oncology through the application of artificial intelligence. The partnership aims to co-develop a novel target identification platform that integrates Aignostics' proprietary AI technology with Bayer's extensive oncology expertise. By leveraging multimodal patient data, including pathology images and molecular profiles, the companies intend to discover new cancer targets and accelerate clinical development for patients with high unmet medical needs. This multi-year agreement focuses on overcoming challenges in disease heterogeneity and improving patient stratification for clinical trials, ultimately fostering the creation of more effective, personalized cancer therapies.

Key Market Players

  • Illumina
  • Thermo Fisher Scientific
  • Roche
  • Guardant Health
  • Foundation Medicine
  • Qiagen
  • BGI
  • IBM Watson Health
  • Bio-Rad
  • Agilent

By Products & Services

By Technology

By Application

By End User

By Region

  • Precision Medicine Platforms
  • Precision Medicine Tools
  • Precision Medicine Services
  • Big Data Analytics
  • Artificial Intelligence
  • Bioinformatics
  • Whole Genome Sequencing
  • Companion Diagnostics
  • NGS
  • Others
  • Oncology
  • Cardiology
  • Respiratory
  • Neurology
  • Immunology
  • Others
  • Pharmaceutical and Biotechnology Companies
  • Healthcare IT
  • Diagnostic Companies
  • Clinical Research Organization
  • Research Institutes
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Precision Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Precision Medicine Market, By Products & Services:
  • Precision Medicine Platforms
  • Precision Medicine Tools
  • Precision Medicine Services
  • Precision Medicine Market, By Technology:
  • Big Data Analytics
  • Artificial Intelligence
  • Bioinformatics
  • Whole Genome Sequencing
  • Companion Diagnostics
  • NGS
  • Others
  • Precision Medicine Market, By Application:
  • Oncology
  • Cardiology
  • Respiratory
  • Neurology
  • Immunology
  • Others
  • Precision Medicine Market, By End User:
  • Pharmaceutical and Biotechnology Companies
  • Healthcare IT
  • Diagnostic Companies
  • Clinical Research Organization
  • Research Institutes
  • Precision Medicine Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Market.

Available Customizations:

Global Precision Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Precision Medicine Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Precision Medicine Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Products & Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services)

5.2.2.  By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, NGS, Others)

5.2.3.  By Application (Oncology, Cardiology, Respiratory, Neurology, Immunology, Others)

5.2.4.  By End User (Pharmaceutical and Biotechnology Companies, Healthcare IT, Diagnostic Companies, Clinical Research Organization, Research Institutes)

5.2.5.  By Region

5.2.6.  By Company (2025)

5.3.  Market Map

6.    North America Precision Medicine Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Products & Services

6.2.2.  By Technology

6.2.3.  By Application

6.2.4.  By End User

6.2.5.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Precision Medicine Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Products & Services

6.3.1.2.2.  By Technology

6.3.1.2.3.  By Application

6.3.1.2.4.  By End User

6.3.2.    Canada Precision Medicine Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Products & Services

6.3.2.2.2.  By Technology

6.3.2.2.3.  By Application

6.3.2.2.4.  By End User

6.3.3.    Mexico Precision Medicine Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Products & Services

6.3.3.2.2.  By Technology

6.3.3.2.3.  By Application

6.3.3.2.4.  By End User

7.    Europe Precision Medicine Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Products & Services

7.2.2.  By Technology

7.2.3.  By Application

7.2.4.  By End User

7.2.5.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Precision Medicine Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Products & Services

7.3.1.2.2.  By Technology

7.3.1.2.3.  By Application

7.3.1.2.4.  By End User

7.3.2.    France Precision Medicine Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Products & Services

7.3.2.2.2.  By Technology

7.3.2.2.3.  By Application

7.3.2.2.4.  By End User

7.3.3.    United Kingdom Precision Medicine Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Products & Services

7.3.3.2.2.  By Technology

7.3.3.2.3.  By Application

7.3.3.2.4.  By End User

7.3.4.    Italy Precision Medicine Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Products & Services

7.3.4.2.2.  By Technology

7.3.4.2.3.  By Application

7.3.4.2.4.  By End User

7.3.5.    Spain Precision Medicine Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Products & Services

7.3.5.2.2.  By Technology

7.3.5.2.3.  By Application

7.3.5.2.4.  By End User

8.    Asia Pacific Precision Medicine Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Products & Services

8.2.2.  By Technology

8.2.3.  By Application

8.2.4.  By End User

8.2.5.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Precision Medicine Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Products & Services

8.3.1.2.2.  By Technology

8.3.1.2.3.  By Application

8.3.1.2.4.  By End User

8.3.2.    India Precision Medicine Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Products & Services

8.3.2.2.2.  By Technology

8.3.2.2.3.  By Application

8.3.2.2.4.  By End User

8.3.3.    Japan Precision Medicine Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Products & Services

8.3.3.2.2.  By Technology

8.3.3.2.3.  By Application

8.3.3.2.4.  By End User

8.3.4.    South Korea Precision Medicine Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Products & Services

8.3.4.2.2.  By Technology

8.3.4.2.3.  By Application

8.3.4.2.4.  By End User

8.3.5.    Australia Precision Medicine Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Products & Services

8.3.5.2.2.  By Technology

8.3.5.2.3.  By Application

8.3.5.2.4.  By End User

9.    Middle East & Africa Precision Medicine Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Products & Services

9.2.2.  By Technology

9.2.3.  By Application

9.2.4.  By End User

9.2.5.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Precision Medicine Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Products & Services

9.3.1.2.2.  By Technology

9.3.1.2.3.  By Application

9.3.1.2.4.  By End User

9.3.2.    UAE Precision Medicine Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Products & Services

9.3.2.2.2.  By Technology

9.3.2.2.3.  By Application

9.3.2.2.4.  By End User

9.3.3.    South Africa Precision Medicine Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Products & Services

9.3.3.2.2.  By Technology

9.3.3.2.3.  By Application

9.3.3.2.4.  By End User

10.    South America Precision Medicine Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Products & Services

10.2.2.  By Technology

10.2.3.  By Application

10.2.4.  By End User

10.2.5.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Precision Medicine Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Products & Services

10.3.1.2.2.  By Technology

10.3.1.2.3.  By Application

10.3.1.2.4.  By End User

10.3.2.    Colombia Precision Medicine Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Products & Services

10.3.2.2.2.  By Technology

10.3.2.2.3.  By Application

10.3.2.2.4.  By End User

10.3.3.    Argentina Precision Medicine Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Products & Services

10.3.3.2.2.  By Technology

10.3.3.2.3.  By Application

10.3.3.2.4.  By End User

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Precision Medicine Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  Illumina

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Thermo Fisher Scientific

15.3.  Roche

15.4.  Guardant Health

15.5.  Foundation Medicine

15.6.  Qiagen

15.7.  BGI

15.8.  IBM Watson Health

15.9.  Bio-Rad

15.10.  Agilent

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Figure 1:               Global Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 2:               Research & Development Expenditure of Top 5 Countries (USD Billion), As of 2021

Figure 3:               Global Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 4:               Global Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 5:               Global Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 6:               Global Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 7:               Global Precision Medicine Market Share, By Company, By Value, 2020

Figure 8:               Global Precision Medicine Market Share, By Region, By Value, 2016-2026F

Figure 9:               Global Precision Medicine Market Map, By Technology, Market Size (USD Billion) & Growth Rate (%)

Figure 10:            Global Precision Medicine Market Map, By Application, Market Size (USD Billion) & Growth Rate (%)

Figure 11:            North America Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 12:            Estimated Number of New Cancer Cases, North America, 2020

Figure 13:            North America Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 14:            North America Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 15:            North America Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 16:            North America Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 17:            North America Precision Medicine Market Share, By Country, By Value, 2016-2026F

Figure 18:            United States Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 19:            New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages

Figure 20:            United States Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 21:            United States Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 22:            United States Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 23:            United States Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 24:            Canada Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 25:            Canada Hospital Establishments, By Region, 2019 (Units)

Figure 26:            Canada Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 27:            Canada Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 28:            Canada Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 29:            Canada Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 30:            Mexico Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 31:            Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)

Figure 32:            Mexico Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 33:            Mexico Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 34:            Mexico Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 35:            Mexico Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 36:            Europe Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 37:            Leading Cancers in Males in Europe by Incidence and Mortality Common Cancers, 2020

Figure 38:            Europe Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 39:            Europe Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 40:            Europe Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 41:            Europe Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 42:            Europe Precision Medicine Market Share, By Country, By Value, 2016-2026F

Figure 43:            Germany Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 44:            Germany New Cancer Cases, By Type, 2020

Figure 45:            Germany Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 46:            Germany Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 47:            Germany Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 48:            Germany Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 49:            United Kingdom Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 50:            Geriatric Population Numbers & Projections in United Kingdom (Million), 2020

Figure 51:            United Kingdom Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 52:            United Kingdom Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 53:            United Kingdom Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 54:            United Kingdom Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 55:            France Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 56:            France Healthcare Spending, By Value (USD Per Capita), 2015-2019

Figure 57:            France Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 58:            France Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 59:            France Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 60:            France Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 61:            Italy Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 62:            New Cancer Cases in Italy (%), Males, All Ages, 2020

Figure 63:            Italy Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 64:            Italy Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 65:            Italy Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 66:            Italy Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 67:            Spain Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 68:            Number of New Cancer Cases in Spain, By Cancer Site, 2020

Figure 69:            Spain Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 70:            Spain Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 71:            Spain Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 72:            Spain Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 73:            Asia Pacific Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 74:            Number of New Cancer Cases in Asia Pacific (2020)

Figure 75:            Asia Pacific Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 76:            Asia Pacific Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 77:            Asia Pacific Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 78:            Asia Pacific Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 79:            Asia Pacific Precision Medicine Market Share, By Country, By Value, 2016-2026F

Figure 80:            China Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 81:            New Cancer Cases in China (%), 2020

Figure 82:            China Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 83:            China Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 84:            China Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 85:            China Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 86:            India Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 87:            Growing Share of Geriatric Population (Above 60 Years) in India (2015-2019)

Figure 88:            India Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 89:            India Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 90:            India Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 91:            India Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 92:            Japan Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 93:            Japan Total Health Expenditure as a share of GDP, 2015- 2019

Figure 94:            Japan Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 95:            Japan Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 96:            Japan Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 97:            Japan Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 98:            South Korea Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 99:            New Cancer Cases in South Korea (%), 2019

Figure 100:          South Korea Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 101:          South Korea Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 102:          South Korea Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 103:          South Korea Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 104:          Australia Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 105:          % of Public and Private Hospitals in Australia, 2020

Figure 106:          Australia Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 107:          Australia Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 108:          Australia Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 109:          Australia Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 110:          Singapore Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 111:          Singapore Leading Causes of Death, As of 2020

Figure 112:          Singapore Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 113:          Singapore Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 114:          Singapore Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 115:          Singapore Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 116:          South America Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 117:          Estimated Number of New Cancer Cases, South America in 2020

Figure 118:          South America Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 119:          South America Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 120:          South America Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 121:          South America Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 122:          South America Precision Medicine Market Share, By Country, By Value, 2016-2026F

Figure 123:          Brazil Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 124:          Brazil Healthcare Spending, By Value (USD Per Capita), 2015-2019

Figure 125:          Brazil Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 126:          Brazil Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 127:          Brazil Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 128:          Brazil Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 129:          Argentina Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 130:          Argentina Bioinformatics Market Size, By Value (USD Billion), 2016-2026F

Figure 131:          Argentina Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 132:          Argentina Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 133:          Argentina Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 134:          Argentina Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 135:          Colombia Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 136:          New Cancer Cases in Colombia (%), 2019

Figure 137:          Colombia Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 138:          Colombia Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 139:          Colombia Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 140:          Colombia Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 141:          Middle East & Africa Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 142:          Estimated Number of New Cancer Cases, Middle East & Africa in 2020

Figure 143:          Middle East & Africa Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 144:          Middle East & Africa Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 145:          Middle East & Africa Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 146:          Middle East & Africa Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 147:          Middle East & Africa Precision Medicine Market Share, By Country, By Value, 2016-2026F

Figure 148:          South Africa Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 149:          South Africa New Cancer Cases, By Type, 2020

Figure 150:          South Africa Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 151:          South Africa Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 152:          South Africa Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 153:          South Africa Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 154:          Saudi Arabia Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 155:          Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)

Figure 156:          Saudi Arabia Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 157:          Saudi Arabia Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 158:          Saudi Arabia Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 159:          Saudi Arabia Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 160:          UAE Precision Medicine Market Size, By Value (USD Billion), 2016-2026F

Figure 161:          UAE Health Expenditure (% of GDP), 2015-2019

Figure 162:          UAE Precision Medicine Market Share, By Products & Services, By Value, 2016-2026F

Figure 163:          UAE Precision Medicine Market Share, By Technology, By Value, 2016-2026F

Figure 164:          UAE Precision Medicine Market Share, By Application, By Value, 2016-2026F

Figure 165:          UAE Precision Medicine Market Share, By End User, By Value, 2016-2026F

Figure 166:          New Cancer Cases, By Type (2020)

Figure 167:          Global Population Ages 65 & Above (% of Total Population), 2016-2019

Frequently asked questions

Frequently asked questions

The market size of the Global Precision Medicine Market was estimated to be USD 118.35 Billion in 2025.

North America is the dominating region in the Global Precision Medicine Market.

Bioinformatics segment is the fastest growing segment in the Global Precision Medicine Market.

The Global Precision Medicine Market is expected to grow at 11.51% between 2026 to 2031.

Related Reports
Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.